Abstract
Flunitrazepam is an hypnotic benzodiazepine marketed in different European countries. Epidemiological studies have shown that it is frequently abused by opioid addicts. In a survey, “liking” scores for flunitrazepam in methadone maintenance patients were higher than ratings for other benzodiazepines. A double-blind, placebo controlled, crossover clinical trial was conducted to assess the acute behavioral effects of flunitrazepam (0.05 and 2 mg) and triazolam (0.25 and 0.50 mg) in healthy male volunteers. Drug effects on physiological measures, psychomotor performance, and subjective rating scales, including specific questionnaires to evaluate abuse liability (e.g., ARCI or “liking” scores), were assessed before and 6 h after drug administration. Flunitrazepam 2 mg produced the most intense disruptive effects on all the performance tasks, triazolam 0.50 impaired performance except balance. All study drugs at all doses produced sedation symptoms in all or part of the subjective effects questionnaires. Only flunitrazepam 2 mg induced significative increases in some of the scales (“liking”, “good effects”, “high”) that could be related to a possible abuse potential. The results seem to indicate that flunitrazepam, when administered to healthy subjects, produces some pleasurable subjective feelings, that could indicate a higher abuse liability of this drug as compared with other benzodiazepines.
Similar content being viewed by others
References
Association of the British Pharmaceutical Industry (1994) Data Sheet Compendium. Datapharm Publication Ltd, London
Arendt RM, Grenblatt DJ, deJong RH, Bonin JD, Abernathy DR, Ehrenberg BL, Giles HG, Sellers EM, Shader RI (1983) In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution. J Pharmacol Exp Ther 227:98–106
Balter MB, Manheimer DI, Mellinger GD, Uhlenhuth EH (1984) A cross-national comparison of anti-anxiety/sedative drug use. Curr Med Res Opin 8 [suppl 4]:5–20
Barnas C, Rossmann M, Roessler H, Reimer Y, Fleischacker WW (1992) Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: familiarity and preference. J Clin Psychopharmacol 12:397–402
Berlin I, Warot D, Hergueta T, Molinier P, Bagot C, Puech AJ (1993) Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. J Clin Psychopharmacol 13:100–106
Bond A, Seijas D, Dawling S, Lader M (1994) Systemic absorption and abuse liability of snorted flunitrazepam. Addiction 89 821–830
Cappell H, Busto U, Kay G, Naranjo CA, Sellers EM, Sanchez-Craig M (1987) Drug deprivation and reinforcement by diazepam in a dependent population. Psychopharmacology 91:154–160
de Wit H, Johanson CE, Uhlenhuth EH (1984) Reinforcing properties of lorazepam in normal volunteers. Drug Alcohol Depend 13:31–41
de Wit H, Griffiths RR, (1991) Testing the abuse liability of anxiolytic and hypnotic drugs in humans. Drug Alcohol Depend 28:83–111
DuPont RL (1988) Abuse of benzodiazepines: the problems and the solutions. Am J Drug Alcohol Abuse 14 [suppl 1]:1–69
Evans SM, Funderburk FR, Griffiths RR (1990) Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther 255:1246–1255
Farré M, Camí J (1991) Pharmacokinetic considerations in abuse liability evaluations. Br J Addict 86:1601–1606
Farré M, De la Torre R, Llorente M, Lamas X, Ugena B, Segura J, Camí J (1993) Alcohol and cocaine interactions in humans J Pharmacol Exp Ther 266:1364–1373
Grahnén A, Wnnerlund P Dahlström B, Eckernäs S A (1991) Inter- and intraindividual variability in the concentration-effect (sedation) relationship of flunitrazepam. Br J Clin Pharmacol 31:89–92
Griffiths RR, Sannerud CA (1987) Abuse and dependence on benzodiazepines and other anxiolytic/sedative drugs. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress, 3rd edn. Raven Press, New York, pp 1535–1541
Haertzen CA (1974) An overview of the Addiction Research Center Inventory: an appendix and manual of scales. DHEW Pub. no. (ADM) 79. Department of Health Education and Welfare, Washington, D.C.
Hannington-Kiff JG (1970) Measurements of recovery from outpatient general anaesthesia with a simple ocular test. BMJ 3:132–135
Hindmarch I (1980) Psychomotor function and psychoactive drugs. Br J Clin Pharmacol 10:189–209
Iguchi MY, Handelsman L, Bickel WK, Griffiths RR (1993) Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug Alcohol Depend 32:257–266
Ingum J, Bjorklund R, Bjorneboe A, Christophersen AS, Dahlin E, Morland J (1992) Relationship between drug plasma concentrations and psychomotor performance after single doses of ethanol and benzodiazepines. Psychopharmacology 107:11–17
Ingum J, Pettersen G, Sager G, Morland J (1994) Relationship between unbound plasma concentrations and various psychomotor and subjective affects after intakes of diazepam and flunitrazepam. Int Clin Psychopharmacol 9:115–121
King MB (1994) Long-term benzodiazepine users — a mixed bag. Addiction 89:1367–1370
Lamas X, Farré M, Llorente M, Camí J (1994) Spanish version of the 49-item short form of the Addiction Research Center Inventory (ARCI). Drug Alcohol Depend 35:203–209
Martin WR, Sloan JW, Sapiro JD, Jasinski DR (1971) Physiologic, subjective, and behavioral effects of amphetamine, metamphetamine, ephedrine, phenmetrazine and metilphenidate in man. Clin Pharmacol Ther 12:245–258
Mattila MAK, Larni HM (1980). Flunitrazepam: a review of its pharmacological properties and therapeutic use. Drugs 20:353–374
Mattila ME, Mattila MJ, Nuotto E (1992) Caffeine moderately antagonizes the effects of triazolam and zopiclone on the psychomotor performance of healthy volunteers. Pharmacol Toxicol 70:286–289
McLeod DR, Griffiths RR, Bigelow GE, Yingling J (1982) An automated version of the digit symbol substitution test (DSST). Behav Res Methods Instrum 14:463–466
McNair DR, Lorr M, Droppleman LF (1971) Profile of mood states. Educational and Industrial Testing Service, San Diego, CA
Navaratnam V, Foong K (1990) Adjunctive drug use among opiate addicts. Curr Med Res Opin 11:611–619
Patat A, Foulhoux P, Klein MJ (1986) Etude des effects résiduels sur l'equilibre de trois hypnotiques (loprazolam, flunitrazépam, triazolam) appréciés par l'analyse spectrale des oscillations posturales. Thérapie 41:443–447
Physician's Desk Reference (1995) Medical Economics Data, Montvale, N.J.
Preston KL, Guarino JJ, Kirk WT, Griffiths RR (1989) Evaluation of the abuse liability of methocarbamol. J Pharmacol Exp Ther 248:1146–1157
Preston KL, Wolf B, Guarino JJ, Griffiths RR (1992) Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability. J Pharmacol Exp Ther 262:707–720
Rao S, Sherbaniuk RW, Prasad K, Lee SJK, Sproule BJ (1972). Cardiopulmonary effects of diazepam. Clin Pharmacol Ther 14:182–189
Roache JD, Griffiths RR (1985) Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability. J Pharmacol Exp Ther 234:120–133
Robin DW, Hasan SS, Lichtenstein MJ, Shiavi RG, Wood AJ (1991) Dose-related effect of triazolam on postural sway. Clin Pharmacol Ther 49:581–588
Rush CR, Higgins ST, Bickel WK, Hughes JR (1993a) Acute effects of triazolam and lorazepam on human learning, performeance and subject ratings. J Pharmacol Exp Ther 264:1218–1226
Rush CR, Higgins ST, Hughes JR, Bickel WK (1993b) A comparison of the acute effects of triazolam and temazepam in healthy volunteers. Psychopharmacology 112:407–414
San L, Tato J, Torrens M, Castillo C, Farré M, Camí J (1993) Flunitrazepam consumption among heroin addicts admitted for inpatient detoxification. Drug Alcohol Depend 32:281–286
Sancibrain M, Serrano JS, Minano FJ (1991) Opioid and prostaglandin mechanisms ivolved in the effects of GABAergic drugs on body temperature. Gen Pharmacol 22 [Suppl 2]:259–262
Stitzer ML, Griffiths RR, McLellan AT, Grabowski J, Hawthorne JW (1981) Diazepam use among methadone maintenance patients: patters and dosages. Drug Alcohol Depend 8:189–199
Terán MT, Farré M, Lamas X, Ugena B, Camí J (1993) Subjective and psychomotor effects of flunitrazepam in healthy volunteers. In: Harris LS, (ed) Problems of drug dependence 1993. NIDA Res Mon 132. Supt of Doc, US Govt Printing Office, DHHS (ADM) 93-3505, Washington, D.C., p 348
Wechsler Adult Intelligence Scale-Revised (1981) The Psychological Corporation, New York, N.Y.
Zacny JP, Lichtor JJ, de Wit H (1992a) Subjective, behavioral, and physiological responses to intravenous dezocine in healthy volunteers. Anesth Analg 74:523–530
Zacny JP, Lichtor JJ, Zaragoza JG, de Wit H (1992b) Subjective and behavioral responses to intravenous fentanly in healthy volunteers. Psychopharmacology 107:319–326
Zacny JP, Lichtor JJ, Flemming D, Coalson DW, Thomson WK (1994a) A dose-response analysis of the subjective, psychomotor and physiological effects of intravenous morphine in healthy volunteers. J Pharmacol Exp Ther 268:1–9
Zacny JP, Lichtor JJ, Thapar P, Coalson DW, Flemming D, Thomson WK (1994b). Comparing the subjective, psychomotor and physiological effects of intravenous butorphanol and morphine in healthy volunteers. J Pharmacol Exp Ther 270:579–588
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Farré, M., Terán, M.T. & Camí, J. A comparison of the acute behavioral effects of flunitrazepam and triazolam in healthy volunteers. Psychopharmacology 125, 1–12 (1996). https://doi.org/10.1007/BF02247387
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02247387